3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Brain Neoplasms
5
Squamous Cell Carcinoma of Head and Neck
4
Polycythemia Vera
4
Glioblastoma
4
Meningioma
3
Leukemia, Myeloid, Acute
3
Pharyngeal Neoplasms
2
Paranasal Sinus Neoplasms
2
Neoplasms
2
Laryngeal Neoplasms
2
Head and Neck Neoplasms
2
Gliosarcoma
2
Thrombocytosis
1
Thrombocythemia, Essential
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Papillomavirus Infections
1
Oropharyngeal Neoplasms
1
Nose Neoplasms
1
Myeloproliferative Disorders
1
Myelodysplastic Syndromes
1
Lymphoma, Non-Hodgkin
1
Hodgkin Disease
1
Glioma
1
Epstein-Barr Virus Infections
1
Carcinoma, Squamous Cell
1
Carcinoma
1
Astrocytoma
1
Adenocarcinoma
1
Interventions
tislelizumab
4
talazoparib
4
pembrolizumab
4
Docetaxel
4
Nivolumab
3
PM 01183
2
MLN 8237
2
Itraconazole
2
Fluorouracil
2
Cisplatin
2
Carboplatin
2
zimberelimab
1
utomilumab
1
urelumab
1
ulixertinib
1
trifluridine tipiracil drug combination
1
sitravatinib
1
sapanisertib
1
pexidartinib
1
pevonedistat
1
peposertib
1
niraparib
1
mogamulizumab
1
lenvatinib
1
ixabepilone
1
eribulin
1
durvalumab
1
dalotuzumab
1
avelumab
1
ascrinvacumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Advanced Solid Tumors
×
Hydroxyurea
×
Clear all
No trials found.